Cochlear

Cochlear

Helps transform the way people understand and treat hearing loss.

HQ location
Sydney, Australia
Launch date
Market cap
$12.7b
Enterprise value
$12.6b
Share price
AUD304.14 COH.AX
  • Healthcare
  • Edit
loading funding rounds…

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
AUD2021202220232024202520262027
Revenues0000000000000000000000000000
% growth13 %10 %17 %15 %6 %11 %11 %
EBITDA0000000000000000000000000000
% EBITDA margin31 %29 %25 %26 %26 %27 %27 %
Profit0000000000000000000000000000
% profit margin22 %18 %16 %16 %17 %16 %17 %
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
R&D % of revenue13 %13 %13 %12 %---

Source: Company filings or news article, Equity research estimates

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Cochlear

Edit
Nyxoah
exited
Oticon Medical
ACQUISITION by Cochlear Apr 2022